Bayer study 15791 - Mechanism of action (MoA) study 3month oral dosing of Vilaprisan or Ulipristal in patients with uterine fibroids scheduled for hysterectomy

  • Hilary Critchley (Owner)
  • Catherine Murray (Creator)
  • Rohan Chodankar (Creator)
  • Alison Murray (Creator)
  • Moira Nicol (Creator)
  • Alistair Williams (Creator)



Essential source documentation for the study.
Date made available2021
PublisherEdinburgh DataVault
Geographical coverageLothian

Cite this